Bio-Rad [BIO.B] vs Masimo [MASI] Detailed Stock Comparison
Bio-Rad
NYSE
Loading...
Masimo
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Bio-Rad wins in 12 metrics, Masimo wins in 6 metrics, with 0 ties. Bio-Rad appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bio-Rad | Masimo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.30 | 129.16 | Bio-Rad |
| Price-to-Book Ratio | 0.94 | 7.65 | Bio-Rad |
| Debt-to-Equity Ratio | 19.73 | 61.58 | Bio-Rad |
| PEG Ratio | N/A | 0.60 | N/A |
| EV/EBITDA | 16.38 | 55.04 | Bio-Rad |
| Profit Margin (TTM) | 12.50% | -21.32% | Bio-Rad |
| Operating Margin (TTM) | 12.19% | 17.12% | Masimo |
| EBITDA Margin (TTM) | 12.19% | 17.12% | Masimo |
| Return on Equity | 4.59% | -22.37% | Bio-Rad |
| Return on Assets (TTM) | 1.59% | 1.84% | Masimo |
| Free Cash Flow (TTM) | $266.20M | $145.30M | Bio-Rad |
| 1-Year Return | -24.40% | 23.92% | Masimo |
| Price-to-Sales Ratio (TTM) | 2.84 | 3.70 | Bio-Rad |
| Enterprise Value | $6.72B | $8.47B | Masimo |
| EV/Revenue Ratio | 2.63 | 3.93 | Bio-Rad |
| Gross Profit Margin (TTM) | 52.99% | 62.90% | Masimo |
| Revenue per Share (TTM) | $92 | $40 | Bio-Rad |
| Earnings per Share (Diluted) | $11.08 | $-5.09 | Bio-Rad |
| Beta (Stock Volatility) | 0.91 | 1.21 | Bio-Rad |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Bio-Rad vs Masimo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bio-Rad | 0.00% | 0.00% | -4.15% | -1.21% | -20.83% | -24.12% |
| Masimo | 3.04% | -3.41% | -6.07% | -0.85% | -12.94% | -11.83% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bio-Rad | -24.40% | -52.39% | -52.46% | 82.57% | 194.74% | 348.37% |
| Masimo | 23.92% | -2.08% | -32.37% | 258.06% | 551.60% | 642.41% |
Performance & Financial Health Analysis: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Market Information | ||
| Market Cap | $7.26B | $7.97B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2 | 1,090,790 |
| 90 Day Avg. Volume | 11 | 743,070 |
| Last Close | $247.05 | $148.63 |
| 52 Week Range | $225.29 - $359.22 | $107.98 - $194.88 |
| % from 52W High | -31.23% | -23.73% |
| All-Time High | $818.60 (Sep 06, 2021) | $305.21 (Nov 15, 2021) |
| % from All-Time High | -69.82% | -51.30% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.08% |
| Quarterly Earnings Growth | 0.02% | 2.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | -0.21% |
| Operating Margin (TTM) | 0.12% | 0.17% |
| Return on Equity (TTM) | 0.05% | -0.22% |
| Debt to Equity (MRQ) | 19.73 | 61.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $263.42 | $19.20 |
| Cash per Share (MRQ) | $50.76 | $2.75 |
| Operating Cash Flow (TTM) | $534.20M | $176.60M |
| Levered Free Cash Flow (TTM) | $223.40M | $92.86M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.30 | 129.16 |
| Forward P/E | N/A | 31.63 |
| PEG Ratio | N/A | 0.60 |
| Price to Sales (TTM) | 2.84 | 3.70 |
| Price to Book (MRQ) | 0.94 | 7.65 |
| Market Capitalization | ||
| Market Capitalization | $7.26B | $7.97B |
| Enterprise Value | $6.72B | $8.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.63 | 3.93 |
| Enterprise to EBITDA | 16.38 | 55.04 |
| Risk & Other Metrics | ||
| Beta | 0.91 | 1.21 |
| Book Value per Share (MRQ) | $263.42 | $19.20 |
Financial Statements Comparison: Bio-Rad vs Masimo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Revenue/Sales | $585.40M | $372.00M |
| Cost of Goods Sold | $279.40M | $138.00M |
| Gross Profit | $306.00M | $234.00M |
| Research & Development | $73.50M | $33.90M |
| Operating Income (EBIT) | $23.70M | $80.70M |
| EBITDA | $98.50M | $90.70M |
| Pre-Tax Income | $83.40M | $68.40M |
| Income Tax | $19.40M | $21.20M |
| Net Income (Profit) | $64.00M | $-170.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Cash & Equivalents | $521.40M | $130.80M |
| Total Current Assets | $3.04B | $1.18B |
| Total Current Liabilities | $506.60M | $546.50M |
| Long-Term Debt | $1.33B | $657.70M |
| Total Shareholders Equity | $6.68B | $946.40M |
| Retained Earnings | $7.48B | $1.32B |
| Property, Plant & Equipment | $681.70M | $183.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Operating Cash Flow | $156.00M | $62.60M |
| Capital Expenditures | $-34.40M | $17.00M |
| Free Cash Flow | $95.50M | $27.00M |
| Debt Repayment | $-100,000 | $-78.80M |
| Common Stock Repurchase | $-101.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BIO.B | MASI |
|---|---|---|
| Shares Short | 102 | 3.27M |
| Short Ratio | N/A | 6.08 |
| Short % of Float | 0.00% | 0.09% |
| Average Daily Volume (10 Day) | 2 | 1,090,790 |
| Average Daily Volume (90 Day) | 11 | 743,070 |
| Shares Outstanding | 28.01M | 53.60M |
| Float Shares | 18.51M | 46.34M |
| % Held by Insiders | 0.98% | 0.06% |
| % Held by Institutions | 0.00% | 1.08% |
Dividend Analysis & Yield Comparison: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |